CompoAtlas

Cardarin

Natural health product licensed in Canada

Licence holder
Naturo Aid Pharmaceutical Inc.
NPN or DIN-HM
80028946
Status
Active licence
Licence date
9 January 2012
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
2,5-Cyclohexadiène-1,4-dione, 2-[(2E ,6E ,10E ,14E ,18E ,22E ,26E , 30E ,34E )-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Source : Yeast fermentation

45 mgNot calculated
3,3',4',5,7-Pentahydroxyflavone

Source : Sophora japonica, bourgeon floral

50 mgNot calculated
Magnésium

Source : Magnesium hydrolyzed vegetable protein (HVP) chelate

70 mg420,000 µg
Magnésium

Source : Citrate de magnésium

70 mg420,000 µg
Potassium

Source : Citrate de potassium

70 mg420,000 µg

Non-medicinal ingredients

Hypromellose, Pullulane, L-leucine, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 2 Capsule ; maximum: 3 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Cardarin helps to maintain and/or support cardiovascular health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80028946

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line